Answers are grounded in this paper and cite their sources.
Retrospective study finds dynamic lipid monitoring may predict chemotherapy response in luminal breast cancer, suggesting personalized treatment could improve outcomes.
Dynamic TC trajectory is a novel metabolic biomarker predicting NAC response in Luminal breast cancer. Integration of dynamic lipid monitoring with clinical features may guide personalized treatment and early intervention.
No takes yet. Share an insight, caveat, or question.
Zeng et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: